Genetic Disease Investigators, LLC Awarded Patent For Dry Eye Treatment


Genetic Disease Investigators, LLC announced the receipt of its second patent, a new and innovative treatment for dry eye.

The research company’s formula works through the body’s autonomic nervous system, stimulating the release and production of specific neurotransmitters that aid in tear production.
For more information, see the press release, “New Patent Awarded for Dry Eye Treatment”